Congratulations to Dr. Jimeno, R01 recipientMar 15, 2021
Antonio Jimeno, MD, PhD, has recently been awarded an R01 entitled Targeting oncogenic Myb fusions in salivary gland cancer with the elongation inhibitor SVC112. This project, supported by the University of Colorado Cancer Center, Cancer League of Colorado, patient philanthropy, and the AC Foundation, is the result of a lot of hard work and collaboration between the labs of Dr. Jimeno and Tin Tin Su, PhD, of CU Boulder. In addition to Dr. Jimeno crediting Dr. Su with providing valuable drug expertise he has also acknowledged Dr. Daniel Bowles for providing his collaborative efforts between the lab and clinic through facilitation of salivary PDXs. In the words of Dr. Jimeno "the saying 'it takes a village' was never more true".